Showing results (71-80 of 133) with videos related to
Sort By:
Pageof 14
Nature Communications|May 25, 2017
An Hsp90 co-chaperone protein in yeast is functionally replaced by site-specific posttranslational modification in humansAbbey D Zuehlke, Michael Reidy, Coney Lin, et al.Nature Structural & Molecular Biology|October 20, 2009
Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domainShinji Tsutsumi, Mehdi Mollapour, Christian Graf, et al.Journal of Clinical Pharmacology|August 28, 2015
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancerAndrew K L Goey, Tristan M Sissung, Cody J Peer, et al.Cancer Chemotherapy and Pharmacology|February 14, 2013
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomasSook Ryun Park, Giovanna Speranza, Richard Piekarz, et al.Oncotarget|January 7, 2017
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunityMikako Ogawa, Yusuke Tomita, Yuko Nakamura, et al.Blood|December 21, 2006
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemiasIvana Gojo, Anchalee Jiemjit, Jane B Trepel, et al.Clinical Medicine Insights. Oncology|November 15, 2016
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001Bryan Oronsky, Scott Caroen, Karen Zeman, et al.Journal of Medicinal Chemistry|March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer TreatmentClaudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.Anti-Cancer Drugs|February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungSanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.Scientific Reports|December 6, 2019
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-MycCarole Sourbier, Christopher J Ricketts, Pei-Jyun Liao, et al.Pageof 14